Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Gower Publishing

- PMLiVE

J&J’s one-dose COVID-19 vaccine proves 66% effective in phase 3 trial

Vaccine was 57% effective against South African strain

- PMLiVE

Keeping up with the developing regulatory requirements for gene and cell therapies

By Clive Glover

- PMLiVE

Kat Arnull joins Golin London as UK group chief strategy officer

Prior to joining Golin, Arnull worked at global communications agency Freuds

- PMLiVE

EU may restrict exports of some COVID-19 vaccines

Proposed strategy follows a confrontation between the EU and AstraZeneca

Creating strong commercial relationships in a COVID world

By Lisa Alderson

- PMLiVE

The UK reasserts that the AZ vaccine is ‘effective across all age groups’

Germany's draft guidance does not recommend the vaccine for people over 65

Think fast, be different: succeeding at speed chess in 2021’s COVID-19 world

The importance of thinking differently, embracing risk, challenging conventional norms and trying new approaches

- PMLiVE

UK trial of Novavax COVID-19 vaccine demonstrates 89.3% efficacy

Vaccine demonstrated 60% efficacy in South Africa study

Holistic Digital Health Engagement and Risk Quantification

Matt Park, Vice President & General Manager (North America) at Dacadoo, explores digital health engagement and health risk quantification in the COVID-19 era, including the roles of gamification, big data,...

Impetus Digital

Can Science Save Us?

Dr. Mark Poznansky, Founder/Blogger at Saved By Science explores the importance of improving health literacy among the general population, along with the scientific and technological innovations that he believes could help save...

Impetus Digital

- PMLiVE

PharmaMar’s cancer drug has ‘potent preclinical efficacy’ against COVID-19

Early study results published in peer-reviewed journal Science

- PMLiVE

How to lead a successful launch in the future

Some themes and questions that may help the next wave of launch teams and leaders

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links